SOPHiA GENETICS SA

NASDAQ:SOPH

3.12 (USD) • At close March 13, 2025
Bedrijfsnaam SOPHiA GENETICS SA
Symbool SOPH
Munteenheid USD
Prijs 3.12
Beurswaarde 208,513,032
Dividendpercentage 0%
52-weken bereik 2.7 - 6.28
Industrie Health Information Services
Sector Healthcare
CEO Dr. Jurgi Camblong M.B.A., Ph.D.
Website https://www.sophiagenetics.com

An error occurred while fetching data.

Over SOPHiA GENETICS SA

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide.

Vergelijkbare Aandelen

Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc.

XERS

4.56 USD

Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc.

MCRB

0.638 USD

Generation Bio Co. logo

Generation Bio Co.

GBIO

0.512 USD

Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc.

PHAT

4.22 USD

Zynex, Inc. logo

Zynex, Inc.

ZYXI

2.905 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)